10-Q Filing

Oruka Therapeutics, Inc. CIK: 907654 Q1 2012

Filing Information

Form Type	10-Q
Accession Number	`0001193125-12-231528`
Period End Date	20120331
Filing Date	20120514
Fiscal Year	2012
Fiscal Period	Q1
XBRL Instance	abio-20120331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 56 Income Statement 54 Cash Flow Statement 89 Stockholders Equity 59

Balance Sheet 56 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.08M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.94M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.23M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.03M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$475.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$269.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.18M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.18M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.18M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$6.21M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.18M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.70M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$66.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$52.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$224.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$204.00K	USD	Point-in-time
Total assets	`Assets`	$4.96M	USD	Point-in-time
Total assets	`Assets`	$6.50M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$126.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$260.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$111.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$78.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherLiabilitiesCurrent`	$350.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherLiabilitiesCurrent`	$357.00K	USD	Point-in-time
Deferred rent, current portion	`DeferredRentCreditCurrent`	$33.00K	USD	Point-in-time
Deferred rent, current portion	`DeferredRentCreditCurrent`	$33.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$754.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$594.00K	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$16.00K	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$8.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$602.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$770.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at March 31, 2012 and December 31, 2011; 12,182,999 shares issued and outstanding at March 31, 2012 and December 31, 2011	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at March 31, 2012 and December 31, 2011; 12,182,999 shares issued and outstanding at March 31, 2012 and December 31, 2011	`CommonStockValue`	$12.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$69.42M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$69.39M	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-65.08M	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-63.67M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-5.74M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-678.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$5.73M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.77M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$4.36M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-38.18M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$7.41M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-115.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-19.69M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-619.00K	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$4.96M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.50M	USD	Point-in-time

Income Statement 54 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$690.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$42.01M	USD	41 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$422.00K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$40.34M	USD	41 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$984.00K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.51M	USD	1 Quarter
Merger transaction costs	`BusinessCombinationAcquisitionRelatedCosts`	$5.47M	USD	41 Qtrs
Restructuring expense, net	`RestructuringCharges`	$2.41M	USD	41 Qtrs
Loss on impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$6.00M	USD	41 Qtrs
Total costs and expenses	`OperatingExpenses`	$96.23M	USD	41 Qtrs
Total costs and expenses	`OperatingExpenses`	$2.20M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$1.41M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.20M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.41M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-96.23M	USD	41 Qtrs
Gain on assignment of patent rights	`GainLossOnAssignmentOfPatentRights`	$2.00M	USD	41 Qtrs
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.28M	USD	41 Qtrs
Interest and other income	`InterestAndOtherIncome`	$2.03M	USD	41 Qtrs
Interest and other income	`InterestAndOtherIncome`	$1.00K	USD	1 Quarter
Interest and other expense	`InterestExpenseDebt`	$1.00K	USD	1 Quarter
Interest and other expense	`InterestExpenseDebt`	$5.00K	USD	1 Quarter
Interest and other expense	`InterestExpenseDebt`	$440.00K	USD	41 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.41M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-67.36M	USD	41 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.21M	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-2.28M	USD	41 Qtrs
Net loss	`NetIncomeLoss`	$-8.42M	USD	Annual
Net loss	`NetIncomeLoss`	$-13.99M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.36M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.43M	USD	Annual
Net loss	`NetIncomeLoss`	$-65.08M	USD	41 Qtrs
Net loss	`NetIncomeLoss`	$-9.14M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net loss	`NetIncomeLoss`	$-511.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-116.00K	USD	8 Qtrs
Net loss	`NetIncomeLoss`	$-1.41M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.24M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.21M	USD	1 Quarter
Less: Accretion of redeemable convertible preferred stock	`PreferredStockAccretionOfRedemptionDiscount`	$245.00K	USD	41 Qtrs
Less: Accretion of redeemable convertible preferred stock	`PreferredStockAccretionOfRedemptionDiscount`	$-17.00K	USD	Annual
Less: Deemed preferred stock dividend for additional common shares issuable under anti-dilution provisions	`PreferredStockDividendsAndOtherAdjustments`	$781.00K	USD	41 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-66.11M	USD	41 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.21M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.41M	USD	1 Quarter
Changes in other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Changes in other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	-	USD	41 Qtrs
Changes in other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Comprehensive loss attributable to common stockholders	`ComprehensiveIncomeNetOfTax`	$-1.41M	USD	1 Quarter
Comprehensive loss attributable to common stockholders	`ComprehensiveIncomeNetOfTax`	$-66.11M	USD	41 Qtrs
Comprehensive loss attributable to common stockholders	`ComprehensiveIncomeNetOfTax`	$-2.21M	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.12	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.25	USD	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.82M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.17M	shares	1 Quarter

Cash Flow Statement 89 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-8.42M	USD	Annual
Net loss	`NetIncomeLoss`	$-13.99M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.36M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.43M	USD	Annual
Net loss	`NetIncomeLoss`	$-65.08M	USD	41 Qtrs
Net loss	`NetIncomeLoss`	$-9.14M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net loss	`NetIncomeLoss`	$-511.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-116.00K	USD	8 Qtrs
Net loss	`NetIncomeLoss`	$-1.41M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.24M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.21M	USD	1 Quarter
Gain on patent rights assignment	`GainLossOnAssignmentOfPatentRights`	$2.00M	USD	41 Qtrs
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.28M	USD	41 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.75M	USD	41 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$14.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$81.00K	USD	1 Quarter
Non-cash interest expense	`PaidInKindInterest`	$211.00K	USD	41 Qtrs
Share-based compensation	`ShareBasedCompensation`	$2.37M	USD	41 Qtrs
Share-based compensation	`ShareBasedCompensation`	$91.00K	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$78.00K	USD	1 Quarter
Issuance of warrants for lease termination	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$377.00K	USD	41 Qtrs
Accretion of liabilities	`AccretionExpense`	$152.00K	USD	41 Qtrs
Impairment of property and equipment	`ImpairmentOfLongLivedAssetsHeldForUse`	$125.00K	USD	41 Qtrs
Impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$6.00M	USD	41 Qtrs
Write-off of deferred tax liability	`WriteOffOfDeferredTaxLiability`	$-2.28M	USD	41 Qtrs
Gain on marketable securities available for sale	`MarketableSecuritiesGainLoss`	$263.00K	USD	41 Qtrs
(Gain) loss from disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-83.00K	USD	41 Qtrs
(Gain) loss from disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-5.00K	USD	1 Quarter
Other, net	`OtherNoncashIncomeExpense`	$-267.00K	USD	41 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$72.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-2.47M	USD	41 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$89.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-20.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-7.27M	USD	41 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-20.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.06M	USD	41 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-134.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$323.00K	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-19.14M	USD	41 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-160.00K	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-123.00K	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$29.00K	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-41.00K	USD	41 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$8.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-95.00M	USD	41 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.66M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.94M	USD	1 Quarter
Cash received from Merger	`CashAcquiredFromAcquisition`	$30.39M	USD	41 Qtrs
Payment of deferred transaction costs	`OtherPaymentsToAcquireBusinesses`	$1.19M	USD	41 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.88M	USD	41 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.00K	USD	1 Quarter
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$15.37M	USD	41 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$1.00K	USD	1 Quarter
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$358.00K	USD	41 Qtrs
Proceeds from patent rights assignment	`ProceedsFromSaleOfIntangibleAssets`	-	USD	1 Quarter
Proceeds from patent rights assignment	`ProceedsFromSaleOfIntangibleAssets`	$2.00M	USD	41 Qtrs
Proceeds from patent rights assignment	`ProceedsFromSaleOfIntangibleAssets`	-	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$45.05M	USD	41 Qtrs
Proceeds from issuance of convertible notes payable and related warrants for common stock	`ProceedsFromConvertibleDebt`	$10.84M	USD	41 Qtrs
Proceeds from issuance of bank note payable	`ProceedsFromNotesPayable`	$4.00M	USD	41 Qtrs
Proceeds from stock subject to repurchase	`ProceedsFromIssuanceOfRedeemablePreferredStock`	$38.00K	USD	41 Qtrs
Proceeds from the issuance of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$32.32M	USD	41 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$12.58M	USD	41 Qtrs
Repayment of principal on bank note payable	`RepaymentsOfNotesPayable`	$4.00M	USD	41 Qtrs
Repayment of principal on convertible notes payables	`RepaymentsOfConvertibleDebt`	$105.00K	USD	41 Qtrs
Repayment of principal on vendor finance agreement	`RepaymentOfPrincipalOnVendorFinanceAgreement`	-	USD	1 Quarter
Repayment of principal on vendor finance agreement	`RepaymentOfPrincipalOnVendorFinanceAgreement`	-	USD	1 Quarter
Repayment of principal on vendor finance agreement	`RepaymentOfPrincipalOnVendorFinanceAgreement`	$146.00K	USD	41 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-60.00K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$54.17M	USD	41 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.94M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.72M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.23M	USD	41 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.08M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.94M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.23M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.03M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.08M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.94M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.23M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.03M	USD	Point-in-time
Interest paid	`InterestPaid`	$112.00K	USD	41 Qtrs
Accrued interest on notes payable converted to equity	`AccruedInterestOnNotesPayableConvertedToEquity`	$163.00K	USD	41 Qtrs
Warrant issued in connection with credit facility	`WarrantIssuedInConnectionWithCreditFacility`	$111.00K	USD	41 Qtrs
Accrued deferred transaction costs	`AccruedDeferredTransactionCosts`	$482.00K	USD	41 Qtrs
Vendor finance agreement	`VendorFinanceAgreement`	$281.00K	USD	41 Qtrs
Vendor finance agreement	`VendorFinanceAgreement`	$146.00K	USD	1 Quarter
Vendor finance agreement	`VendorFinanceAgreement`	$134.00K	USD	1 Quarter

Stockholders Equity 59 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-5.74M	USD	Point-in-time
Balance	`StockholdersEquity`	$-678.00K	USD	Point-in-time
Balance	`StockholdersEquity`	$5.73M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.77M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.36M	USD	Point-in-time
Balance	`StockholdersEquity`	$-38.18M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.41M	USD	Point-in-time
Balance	`StockholdersEquity`	$-115.00K	USD	Point-in-time
Balance	`StockholdersEquity`	$-19.69M	USD	Point-in-time
Balance	`StockholdersEquity`	$-619.00K	USD	Point-in-time
Registration statement costs for subsequent resale registration of shares issued in December 2011 equity offering	`RegistrationStatementCosts`	$-60.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$845.00K	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$39.00K	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$91.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$308.00K	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$50.00K	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$545.00K	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$458.00K	USD	Annual
Estimated fair value of warrants issued in connection with convertible notes payable	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$399.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.00K	USD	8 Qtrs
Issuance of common stock upon exercise of stock options, for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$114.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$16.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$54.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$139.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-8.42M	USD	Annual
Net loss	`NetIncomeLoss`	$-13.99M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.36M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.43M	USD	Annual
Net loss	`NetIncomeLoss`	$-65.08M	USD	41 Qtrs
Net loss	`NetIncomeLoss`	$-9.14M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net loss	`NetIncomeLoss`	$-511.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-116.00K	USD	8 Qtrs
Net loss	`NetIncomeLoss`	$-1.41M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.24M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.21M	USD	1 Quarter
Deemed preferred stock dividend for additional common shares issuable under anti-dilution provision	`DividendsPreferredStockStock`	$781.00K	USD	Annual
Restricted stock release from restriction	`AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction`	$75.00K	USD	Annual
Conversion of convertible notes and related accrued interest	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$33.78M	USD	Annual
Conversion of warrants for preferred stock	`AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock`	$36.00K	USD	Annual
Merger with Nuvelo, Inc.	`StockIssuedDuringPeriodValueAcquisitions`	$11.91M	USD	Annual
Issuance of common stock under employee stock purchase plan and upon vesting of restricted stock units	`StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan`	$2.00K	USD	Annual
Estimated fair value of warrants issued in connection with lease termination	`AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued`	$377.00K	USD	Annual
Accretion of offering costs of redeemable convertible preferred stock	`PreferredStockAccretionOfRedemptionDiscount`	$245.00K	USD	41 Qtrs
Accretion of offering costs of redeemable convertible preferred stock	`PreferredStockAccretionOfRedemptionDiscount`	$-17.00K	USD	Annual
Issuance of stock	`StockIssuedDuringPeriodValueNewIssues`	$4.02M	USD	Annual
Issuance of stock	`StockIssuedDuringPeriodValueNewIssues`	$7.18M	USD	Annual
Issuance of stock	`StockIssuedDuringPeriodValueNewIssues`	$7.00K	USD	Annual
Balance	`StockholdersEquity`	$-5.74M	USD	Point-in-time
Balance	`StockholdersEquity`	$-678.00K	USD	Point-in-time
Balance	`StockholdersEquity`	$5.73M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.77M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.36M	USD	Point-in-time
Balance	`StockholdersEquity`	$-38.18M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.41M	USD	Point-in-time
Balance	`StockholdersEquity`	$-115.00K	USD	Point-in-time
Balance	`StockholdersEquity`	$-19.69M	USD	Point-in-time
Balance	`StockholdersEquity`	$-619.00K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.